Evidence map›Paper›PMID 38895515›Full record

ArticleFrontiers in digital health2024

Building national patient registries in Mexico: insights from the MexOMICS Consortium.

Paula Reyes-Pérez, Ana Laura Hernández-Ledesma, Talía V Román-López, Brisa García-Vilchis, Diego Ramírez-González, Alejandra Lázaro-Figueroa, Domingo Martinez, Victor Flores-Ocampo, Ian M Espinosa-Méndez, Lizbet Tinajero-Nieto and 17 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Paula Reyes-Pérez *Laboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Ana Laura Hernández-Ledesma *Laboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Talía V Román-López *Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Brisa García-VilchisLaboratorio de Neurogenómica Cognitiva, Unidad de Investigación de Psicobiología y Neurociencias, Coordinación de Psicobiología y Neurociencias, Facultad de Psicología, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Diego Ramírez-GonzálezDepartamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Alejandra Lázaro-FigueroaLaboratorio de Neurogenómica Cognitiva, Unidad de Investigación de Psicobiología y Neurociencias, Coordinación de Psicobiología y Neurociencias, Facultad de Psicología, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Domingo MartinezLaboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Victor Flores-OcampoLaboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Ian M Espinosa-MéndezDepartamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Lizbet Tinajero-NietoHospital General Regional No. 1, Instituto Mexicano del Seguro Social, Querétaro, Santiago de Querétaro, Mexico.
Angélica Peña-AyalaHospital General Regional No. 1, Instituto Mexicano del Seguro Social, Querétaro, Santiago de Querétaro, Mexico.
Eugenia Morelos-FigaredoHospital Regional, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Morelia, Mexico.
Carlos M Guerra-GaliciaNeurociencias PRISMA AC, San Luis Potosí, Mexico.
Estefania Torres-ValdezHospital General Regional No. 2, Instituto Mexicano del Seguro Social, El Marqués, Mexico.
María Vanessa Gordillo-HuertaHospital General Querétaro, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Santiago de Querétaro, Mexico.
Nadia A Gandarilla-MartínezDepartament of Neurology, Neurological Center, ABC Medical Center, México City, México.
Karla Salinas-BarbozaHospital General de México, Ciudad de México, Mexico.
Guillermo Félix-RodríguezHospital Star Médica Querétaro, Santiago de Querétaro, Mexico.
Gabriel Frontana-VázquezHospital General Regional No. 2, Instituto Mexicano del Seguro Social, El Marqués, Mexico.
Yamil Matuk-PérezFacultad de Medicina, Universidad Autónoma de Querétaro. Unidad de Neurociencias, Hospital Angeles Centro Sur, Santiago de Querétaro, Mexico.
Ingrid Estrada-BellmannMovement Disorders Clinic, Neurology Division, Internal Medicine Department, University Hospital "Dr. José E. González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Deshiré Alpizar-RodríguezResearch Unit, Colegio Mexicano de Reumatología, Ciudad de México, Mexico.
Mayela Rodríguez-ViolanteLaboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
Miguel E RenteríaMental Health and Neuroscience Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Alejandra E Ruíz-ContrerasLaboratorio de Neurogenómica Cognitiva, Unidad de Investigación de Psicobiología y Neurociencias, Coordinación de Psicobiología y Neurociencias, Facultad de Psicología, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Sarael AlcauterDepartamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.
Alejandra Medina-RiveraLaboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To introduce MexOMICS, a Mexican Consortium focused on establishing electronic databases to collect, cross-reference, and share health-related and omics data on the Mexican population. Methods: Since 2019, the MexOMICS Consortium has established three electronic-based registries: the Mexican Twin Registry (TwinsMX), Mexican Lupus Registry (LupusRGMX), and the Mexican Parkinson's Research Network (MEX-PD), designed and implemented using the Research Electronic Data Capture web-based application. Participants were enrolled through voluntary participation and on-site engagement with medical specialists. We also acquired DNA samples and Magnetic Resonance Imaging scans in subsets of participants. Results: The registries have successfully enrolled a large number of participants from a variety of regions within Mexico: TwinsMX ( Conclusions: The MexOMICS registries offer a valuable repository of information concerning the potential interplay of genetic and environmental factors in health conditions among the Mexican population.

Indexed as

geneticsParkinson Diseasepatient registriessystemic lupus erythematosustwins

Identifiers

PMID38895515
PMCPMC11183280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.